Biofrontera Inc. (BFRI)
$0.97+5.43%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $12M
- Beta
- 0.88
- P/E (TTM)
- -1.55
- Short % float
- 1.35%
- Days to cover
- 1.0
- SI change
- -68.4%
- 1W
- -3.96%
- 1M
- -33.56%
- vs SPY 1W
- -5.12%
- vs SPY 1M
- -36.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BFRI?
- LOPJLB’s latest quantitative signal on Biofrontera Inc. (BFRI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BFRI in?
- Biofrontera Inc. (BFRI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Biofrontera Inc. (BFRI) do?
- Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquar…